Please turn JavaScript on
HemOnc.org - A Hematology Oncology Wiki - Recent changes [en] icon

HemOnc.org - A Hematology Oncology Wiki - Recent changes [en]

Want to know the latest news and articles posted on HemOnc.org - A Hematology Oncology Wiki - Recent changes [en]?

Then subscribe to their feed now! You can receive their updates by email, via mobile or on your personal news page on this website.

See what they recently published below.

Website title: HemOnc.org - A Hematology Oncology Wiki

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  10.29 / day

Message History

Created page with "== General information and mechanism of action == From the NCI Thesaurus: "A genetically modified oncolytic viral strain of the herpes simplex type 1 (HSV-1) virus, with potential oncolytic, immunostimulating and antineoplastic activities. Upon administration, vusolimogene oderparepvec specifically targets, infects and replicates in tumor cells only while n...


Read full story

V

← Older revision Revision as of 16:31, 14 August 2026 (One intermediate revision by the same user not shown)Line 563: Line 563: *[[Vorasidenib (Voranigo)]]*[[Vorasidenib (Voranigo)]] *[[Vorinostat (Zolinza)]]*[[Vorinostat (Zolinza)]] *[[Vusolimogene oderparepvec (Tudriqev)]] <span style="color:#cc0000;">'''FDA approved <tim...

Read full story

Created page with "== General information and mechanism of action == Class/mechanism from the NCI Thesaurus: "A modulator of the E3 ubiquitin ligase complex containing cereblon (CRL4-CRBN E3 ubiquitin ligase), with immunomodulating and pro-apoptotic activities. Upon administration, iberdomide specifically binds to the cereblon (CRBN) part of the ligase complex, thereby affect...


Read full story

I

← Older revision Revision as of 15:03, 14 August 2026 Line 246: Line 246:

===I======I===  *[[Iberdomide (Zenbexus)]] <span style="color:#cc0000;">'''FDA approved <time datetime="2026-08-13">August 13, 2026</time>'''</span>   *[[Ibritumomab tiuxetan (Zevalin)]]*[[Ibritumomab tiuxetan (Zevalin)]] *...

Read full story